TE
SNDX icon

Tema ETFs’s Syndax Pharmaceuticals SNDX Stock Holding History

Tema ETFs’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.58M Buy
72,212
+13,864
+24% +$288K 0.05% 216
2026
Q1 		$1.36M Sell
58,348
-41,705
-42% -$906K 0.09% 193
2025
Q4 		$2.1M Sell
100,053
-10,013
-9% -$175K 0.16% 148
2025
Q3 		$1.69M Buy
110,066
+23,765
+28% +$311K 0.14% 182
2025
Q2 		$808K Buy
86,301
+65,132
+308% +$717K 0.21% 116
2025
Q1 		$260K Buy
+21,169
New +$299K 0.08% 135

Other funds holding SNDX

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
HCA
Harbour Capital Advisors Tysons Corner, Virginia $549M AUM 54.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
PRTG
Post Resch Tallon Group Pittsford, New York $145M AUM 25.19% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
HPBT
Hickory Point Bank & Trust Decatur, Illinois $165M AUM 27.01% 1-Year Est. Return

Tema ETFs's SNDX Position: Q2 2026 in Review

Tema ETFs increased its Syndax Pharmaceuticals (SNDX) stake by 24% in Q2 2026, buying an estimated $288K and bringing the position to 72,212 shares worth $1.58M. The position accounts for 0.05% of the portfolio, ranked #216.

Tema ETFs first reported a position in SNDX in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.1M in Q4 2025. 15 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Tema ETFs held 72,212 shares of Syndax Pharmaceuticals worth $1.58M as of Q2 2026.
  • Tema ETFs bought 13,864 Syndax Pharmaceuticals shares in Q2 2026, an estimated $288K.
  • Syndax Pharmaceuticals made up 0.05% of Tema ETFs's portfolio in Q2 2026, its #216 holding.
  • Tema ETFs first reported a position in Syndax Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Tema ETFs's Syndax Pharmaceuticals position peaked at $2.1M in Q4 2025.
  • 15 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.